Two late-stage studies published Wednesday in The Lancet show that Astra's Imfinzi and Merck's Keytruda delayed the progress ...
Public submissions on the Treaty Principles Bill has been extended by a further five days after technical issues prevented ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback